Newt has a fascinating conversation with the billionaire philanthropist, David Rubenstein, author of The American Experiment: Dialogues on a Dream. He is cofounder and co-executive chairman of The Carlyle Group, a global private equity firm. He is also the Chairman of the Boards of Trustees of the John F. Kennedy Center for the Performing Arts and the Council on Foreign Relations. He is an original signer of The Giving Pledge and the host of The David Rubenstein Show on Bloomberg TV and PBS.

 Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Newt has a fascinating conversation with the billionaire philanthropist, David Rubenstein, author of The American Experiment: Dialogues on a Dream. He is cofounder and co-executive chairman of The Carlyle Group, a global private equity firm. He is also the Chairman of the Boards of Trustees of the John F. Kennedy Center for the Performing Arts and the Council on Foreign Relations. He is an original signer of The Giving Pledge and the host of The David Rubenstein Show on Bloomberg TV and PBS. Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a>

Join Newt Gingrich, former U.S. Speaker of the House and Ph.D. historian, for the most diverse, informative, and entertaining podcast available. Every episode is an education.

Join Newt Gingrich, former U.S. Speaker of the House and Ph.D. historian, for the most diverse, informative, and entertaining podcast available. Every episode is an education.

Newt's World

Episode 314: David Rubenstein on The American Experiment

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/6b58f453-8478-4dd9-b84b-ae270173173c/transcript

In Part Five of his "How to Win 2026" series, Newt Gingrich lays out the Republican case on healthcare: what President Trump and congressional Republicans have already done to lower costs and expand choices, and what still needs to be built. American families are paying roughly the price of a new car every year just for job-based health insurance — and still facing narrow networks, sky-high deductibles, and bills nobody can explain. From TrumpRx's historic prescription drug price cuts to price transparency legislation, direct primary care, rural investment, and the Make America Healthy Again initiative, Newt makes the case for moving America from a sick-care system to a true healthcare system — one centered on the person, not the bureaucracy. The closing argument of the series: Republicans are helping Americans pay less today while building a healthier future for tomorrow.

In Part Five of his "How to Win 2026" series, Newt Gingrich lays out the Republican case on healthcare: what President Trump and congressional Republicans have already done to lower costs and expand choices, and what still needs to be built. American families are paying roughly the price of a new car every year just for job-based health insurance &mdash; and still facing narrow networks, sky-high deductibles, and bills nobody can explain. From TrumpRx's historic prescription drug price cuts to price transparency legislation, direct primary care, rural investment, and the Make America Healthy Again initiative, Newt makes the case for moving America from a sick-care system to a true healthcare system &mdash; one centered on the person, not the bureaucracy. The closing argument of the series: Republicans are helping Americans pay less today while building a healthier future for tomorrow.

Episode 1037: How to Win 2026 — Part 5 A Healthier America — Lower Costs, More Choice, Longer Lives

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/ecd16199-ec23-425a-b39c-b4b30053b4e4/transcript

In Part Four of his "How to Win 2026" series, Newt Gingrich makes the case for what he calls "the American Party" — not a new political organization, but a governing platform built on issues where seventy percent or more of Americans already agree, across party lines. Drawing on eight years of polling by his own America's New Majority Project alongside independent pollsters, Newt walks through dozens of issues — voter ID, congressional term limits, middle-class tax cuts, drug pricing transparency, border enforcement, parental rights in education, and more — where supermajorities of Americans agree with each other, even when their elected representatives in Washington don't. Newt is also candid about where his own organization's numbers don't match what other pollsters are finding — and why that transparency matters more than a perfect scorecard.

In Part Four of his "How to Win 2026" series, Newt Gingrich makes the case for what he calls "the American Party" &mdash; not a new political organization, but a governing platform built on issues where seventy percent or more of Americans already agree, across party lines. Drawing on eight years of polling by his own America's New Majority Project alongside independent pollsters, Newt walks through dozens of issues &mdash; voter ID, congressional term limits, middle-class tax cuts, drug pricing transparency, border enforcement, parental rights in education, and more &mdash; where supermajorities of Americans agree with each other, even when their elected representatives in Washington don't. Newt is also candid about where his own organization's numbers don't match what other pollsters are finding &mdash; and why that transparency matters more than a perfect scorecard.

Episode 1036: How to Win 2026 — Part 4 The American Party — Issues That Poll 70 Percent or Higher

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/0a05f3a7-14b2-448a-9508-b4b200580653/transcript

In Part Three of his "How to Win 2026" series, Newt Gingrich tackles the two hardest arguments in the entire 2026 campaign: the economy and Iran. On affordability, Newt makes the Republican case with specific facts and dollar figures: the steepest drop in prescription drug prices in sixty years, GLP-1 medications now available for $149 a month through TrumpRx, $82 billion in individual tax relief claimed in a single filing season, and concrete steps already underway on housing, energy, and regulation. On Iran, Newt is equally direct — the war has not gone as planned, the Iranian regime has proven more determined than expected, and there is no easy exit. But backing down, he argues, means gambling that a regime chanting "death to America" won't eventually make good on it.

In Part Three of his "How to Win 2026" series, Newt Gingrich tackles the two hardest arguments in the entire 2026 campaign: the economy and Iran. On affordability, Newt makes the Republican case with specific facts and dollar figures: the steepest drop in prescription drug prices in sixty years, GLP-1 medications now available for $149 a month through TrumpRx, $82 billion in individual tax relief claimed in a single filing season, and concrete steps already underway on housing, energy, and regulation. On Iran, Newt is equally direct &mdash; the war has not gone as planned, the Iranian regime has proven more determined than expected, and there is no easy exit. But backing down, he argues, means gambling that a regime chanting "death to America" won't eventually make good on it.

Episode 1035: How to Win 2026 — Part 3 The Republican Answer on Affordability and Iran

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/ec49e862-04cb-4336-8d6e-b4b1003d4bb2/transcript

Episode 314: David Rubenstein on The American Experiment

In 1 playlist(s)

Newt's World

Social links

Follow podcast

Recent clips